Discusses the results of a phase III study presented at the Annual Conference of the Japan Society of Hepatology in Osaka, Japan, as of June 25, 2005, regarding the efficacy of combination therapy with PEG interferon (IFN)-伪-2a plus ribavirin for the treatment of patients with hepatitis C ...
PEG IFN-alpha-2a + ribavirin for hepatitis C: less impact on QOLHepatitis-C, treatmentInterferon-alpha-2b, therapeutic usePEG-interferon-alpha-2a, therapeutic useQuality-of-lifeRibavirin, therapeutic use
Autoim mune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C. Dig Dis Sci 2002; 47: 562-563Sagir A,Wettstein M,Heintges T,H(a)ussinger D. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C[J].Digestive Diseases and Sciences,...
1. PEG-IFNalpha2a +リバビリン療法施行中にB型慢性肝炎の急性増悪を起こしたB型C型重複感染の1例 [J] . 宮田央, 宮田學, 工藤正俊 肝脏. 2012,第12期 机译:一例B型C多发感染,在PEG-IFNα2a+利巴韦林治疗期间引起慢性乙型肝炎急性加重 2. ぺグィンターフェロン,リバビリン,シメプレビル3...
The study also found PegIFN-lambda was associated with fewer hematologic (blood cell) toxicities, flu-like symptoms, musculoskeletal symptoms, dose reductions and premature discontinuations than the same dose of PegIFN-alpha-2a. However, in the higher dose groups elevations of ALT and bilirubin wer...
Objective To determine a new therapeutic approach using granulocyte monocyte–colony-stimulating factor (GM-CSF) and pegylated interferonalpha 2a (Peg-IFNα-2a) as adjuvant therapy in patients with adult recurrent respiratory papillomatosis.Otolaryngology: Head and Neck SurgeryTeresita Suter-Montano, MD...
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006;44:728--35.Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, et al. Efficacy of peginterferon alpha-2b in chronic...
The combination of PEG interferon (IFN)-α-2a [Pegasys] plus ribavirin [Copegus] was more effective than IFN-α-2a plus ribavirin in the treatment of hepatitis C virus (HCV) infections in patients coinfected with HIV, according to a study presented at the 11th Conference on Retroviruses and...
Retreatment with peginterferon [PEG IFN]-α-2a [Pegasys] plus ribavirin [Copegus, Rebetol] is effective in patients with hepatitis C who have not responded to therapy with PEG IFN-α-2b [Peglntron] plus ribavirin, according to preliminary results from the ongoing REPEAT study presented at the...
The use of therapeutically effective amount of IFN- alpha or PEG-IFN- alpha in association with a therapeutically effective amount of a pharmaceutically acceptable salt or prodrug of mycophenolic acid for the manufacture of medicaments for treating liver diseases patients. The components are administered...